Alprazolam and Posaconazole interaction

Alprazolam and Posaconazole: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Alprazolam (Alprazolam XR) label · effective 2025-02-11

Major

• taking strong cytochrome P450 3A (CYP3A) inhibitors (e.g., ketoconazole, itraconazole), except ritonavir [see Dosage and Administration (2.5) , Warnings and Precautions (5.5) , Drug Interactions (7.1) ] .

Contraindicationsby drug classView label on DailyMed
Major

• Concomitant use with strong cytochrome P450 3A (CYP3A) inhibitors, except ritonavir.

Contraindicationsby drug classView label on DailyMed
Major

Strong CYP3A Inhibitors Alprazolam XR is contraindicated in patients receiving strong inhibitors of CYP3A such as azole antifungal agents [see Contraindications (4) ] .

Warnings and precautionsby drug classView label on DailyMed
Major

Prevention or management Concomitant use of alprazolam XR with a strong CYP3A4 inhibitor (except ritonavir) is contraindicated [see Contraindications (4) , Warnings and Precautions (5.5) ] .

Drug interactionsby drug classView label on DailyMed
Major

Prevention or management Avoid use and consider appropriate dose reduction when alprazolam XR is coadministered with a moderate or weak CYP3A inhibitor [see Warnings and Precautions (5.5) ] .

Drug interactionsby drug classView label on DailyMed

From the Posaconazole (NOXAFIL) label · effective 2026-02-13

Moderate

Concomitant Use with Midazolam : Noxafil can prolong hypnotic/sedative effects.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Monitor patients and benzodiazepine receptor antagonists should be available.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Increased plasma midazolam concentrations could potentiate and prolong hypnotic and sedative effects.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Patients must be monitored closely for adverse effects associated with high plasma concentrations of midazolam and benzodiazepine receptor antagonists must be available to reverse these effects [see Drug Interactions (7.2) and Clinical Pharmacology (12.3) ] .

Warnings and precautionsby drug classView label on DailyMed
Moderate

Benzodiazepines that are CYP3A4 Substrates Mechanism and Clinical Effect(s) Concomitant use of posaconazole with midazolam increased midazolam plasma concentrations which could potentiate and prolong hypnotic and sedative effects [see Clinical Pharmacology (12.3) ] .

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.